UnaCom Pharmaceutical news
6th August--12 August
Collaboration between Immune Biosolutions and JanssenImmune Biosolutions and Janssen, have announced a research collaboration. The research will explore the development of therapeutic antibodies in oncology. The partnership will use Immune Biosciences' Nebula antibody discovery platform to advance oncology targets that historically have been a challenge for therapeutic development. (Pharmatimes.com 2018)
The Nebula platform utilizes four families of technologies in a single platform to deliver antibody therapies.